跳至主要内容
临床试验/NL-OMON54791
NL-OMON54791招募中不适用

Molecular genetic, host-derived and clinical determinants of long-term survival in glioblastoma (ETERNITY). - Determinants of long-term survival in glioblastoma

European Organisation for Research in Treatment of Cancer (EORTC)0 个研究点目标入组 73 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
73

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age > 18 years at diagnosis
  • - Histopathological diagnosis of glioblastoma (reference histology available)
  • - Survival >5 years from diagnosis
  • - Availability of tumor tissue from initial glioblastoma diagnosis (FFPE or
  • fresh-frozen) to validate the diagnosis centrally
  • - Signed consent form (living patients) or no documentation of previous
  • objection of the patient to any of these purposes, and the meaningful aim of
  • the data / material collection and use to research (deceased patients), and a
  • notification to an ethics committee for the re-use of these data and samples,
  • and any other national requirements
  • Caregivers:
  • - Optional stool collection for in-living caregivers:
  • * > 18 years old
  • * In-living caregiver (spouse, in-living family members, in-living
  • housekeeper)
  • * Exposed to same environment and share meals at a regular basis with patient
  • * The patient that the caregiver is taking care of, has provided or will
  • provide a stool sample
  • * The patient has consented to contact the caregiver for the project.
  • - Optional caregiver questionnaires for in-living caregivers or close
  • caregivers:
  • * > 18 years old
  • * The patient has consented to contact the caregiver for the project
  • * In-living caregiver (spouse, in-living family members, in-living
  • housekeeper) or close caregiver (not in-living family member, not in-living
  • housekeeper)

排除标准

  • Optional stool collection for in-living caregivers
  • - Cancer in the past 3 years (carcinomas in situ in the past 3 years are
  • - IBD (Inflammatory Bowel Disease) e.g. Crohn, Colitis Ulcerosa
  • - Medications for gastro-intestinal motility within the last 3 months
  • - Systemic Antibiotics within the last month
  • - Systemic corticosteroids
  • - Previous extensive gastro-intestinal surgery
  • - Use of probiotics containing live bacteria or yeast
  • - Consent of another caregiver of the same patient

研究者

发起方
European Organisation for Research in Treatment of Cancer (EORTC)

相似试验